Coverage of our peer-reviewed research and news reporting in the healthcare and mainstream press.
An article from The American Journal of Managed Care®’s sister site The Center for Biosimilars® was highlighted by OBR Oncology’s daily newsfeed. The article, “Ahead of FDA Decision on its Pegfilgrastim Biosimilar, Sandoz Sues Amgen,” reported on Sandoz filing suit against Amgen, asking the United States District Court for the Northern District of California for a declaratory judgment of patent noninfringement and invalidity.
Stuck in Prior Auth Purgatory: The Hidden Costs of Health Care Delays
June 19th 2025Delays, denials, and endless paperwork—prior authorization isn’t just a headache for providers; it’s a barrier for patients who need timely care, explains Colin Banas, MD, MHA, chief medical officer with DrFirst.
Listen
Report Reveals Mounting Burdens of Drug Shortages on US Health System
June 27th 2025Vizient's 2024 survey reveals a sharp rise in drug shortages across US health care, with pediatric care hit especially hard and labor costs soaring—but the true impact may go far beyond limited medication access, threatening to disrupt the very foundations of how health systems operate.
Read More